Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
01 1CU Chemie Uetikon GmbH
02 1Aurobindo Pharma Limited
03 1DARMERICA, LLC
04 2Industriale Chimica s.r.l.
05 1Jubilant Pharmova Limited
06 1LETCO MEDICAL, LLC
07 1MEDISCA Inc.
08 1Micro Labs Limited
09 2PROCOS S.p.A.
10 1Professional Compounding Centers of America dba PCCA
11 1Regis Technologies Inc.
12 1SUN PHARMACEUTICAL INDUSTRIES, INC.
01 14-Aminopyridine
02 4DALFAMPRIDINE
03 1DALFAMPRIDINE MICRONIZED
04 7Dalfampridine
05 1dalfampridine
01 1France
02 4India
03 4Italy
04 4U.S.A
05 1United Kingdom
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 54382-125
Start Marketing Date : 2006-07-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63190-0510
Start Marketing Date : 2010-01-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-3143
Start Marketing Date : 2019-02-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-3205
Start Marketing Date : 2020-01-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42571-338
Start Marketing Date : 2019-07-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-5030
Start Marketing Date : 2018-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 46016-5041
Start Marketing Date : 2011-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46016-5042
Start Marketing Date : 2011-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12817-054
Start Marketing Date : 1956-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62756-038
Start Marketing Date : 2023-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
A Dalfampridine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dalfampridine, including repackagers and relabelers. The FDA regulates Dalfampridine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dalfampridine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dalfampridine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dalfampridine supplier is an individual or a company that provides Dalfampridine active pharmaceutical ingredient (API) or Dalfampridine finished formulations upon request. The Dalfampridine suppliers may include Dalfampridine API manufacturers, exporters, distributors and traders.
click here to find a list of Dalfampridine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dalfampridine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dalfampridine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dalfampridine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dalfampridine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dalfampridine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dalfampridine suppliers with NDC on PharmaCompass.
We have 12 companies offering Dalfampridine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
